Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infectionPhilip E Castle, Mark Schiffman, Rolando Herrero, et al.International Journal of Cancer|August 28, 2007
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident diseasePatti E Gravitt, Melinda Butsch Kovacic, Rolando Herrero, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infectionTroy J Kemp, Allan Hildesheim, Alfonso García-Piñeres, et al.Sexually Transmitted Diseases|January 24, 2007
The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual lifeAna Cecilia Rodriguez, Robert Burk, Rolando Herrero, et al.Cancer|April 22, 2003
Stability of archived liquid-based cervical cytologic specimensPhilip E Castle, Diane Solomon, Allan Hildesheim, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2012
A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with menPhilip E Castle, Stephen Follansbee, Sylvia Borgonovo, et al.Vaccine|February 17, 2025
Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)Mónica S Sierra, Loretto J Carvajal, Peter Dull, et al.Cancer Prevention Research (Philadelphia, Pa.)|October 5, 2021
Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact StrategiesAna Ribeiro, Flávia Corrêa, Arn Migowski, et al.Plos One|April 13, 2012
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancerMahboobeh Safaeian, Allan Hildesheim, Paula Gonzalez, et al.Journal of the National Cancer Institute|September 27, 2023
Artificial intelligence-based image analysis in clinical testing: lessons from cervical cancer screeningDidem Egemen, Rebecca B Perkins, Li C Cheung, et al.Pageof 10